Profilo
Magnus Hansson is currently the Chief Medical Officer & VP-Preclinical Development at Abliva AB since 2016.
Previously, he worked as an Associate Professor at Skane University Hospital from 2008 to 2015.
Dr. Hansson obtained a doctorate degree from the University of Lund.
Posizioni attive di Magnus Hansson
| Società | Posizione | Inizio |
|---|---|---|
| ABLIVA AB | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Precedenti posizioni note di Magnus Hansson
| Società | Posizione | Fine |
|---|---|---|
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | 01/12/2015 |
Formazione di Magnus Hansson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
















